Mono Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 17.67 Cr
as on 16-11-2024
- Company Age 2 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.42 Cr
as on 16-11-2024
About Mono Pharmacare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 17.67 Cr.
The company currently has active open charges totaling ₹9.42 Cr.
The Key Managerial Personnel (KMP) at Mono Pharmacare Limited India is Neha Prajapati as CFO. Supal Lakhatariya, Panilamkumar Lakhatariya, Jitendra Dasani, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2022PLC136193
- Company No.
136193
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mono Pharmacare?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Panilamkumar Lakhatariya  | Managing Director | 17-Oct-2022 | Current |
| Neha Prajapati | CFO | 21-Mar-2023 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendra Dasani | Director | 01-Jan-2024 | Current |
| Supal Lakhatariya | Director | 17-Oct-2022 | Current |
| Archit Shah | Director | 17-Oct-2022 | Current |
| Chintan Trivedi | Director | 22-Mar-2023 | Current |
Financial Performance of Mono Pharmacare.
Mono Pharmacare Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mono Pharmacare?
Unlock access to Mono Pharmacare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Supal Distributors LlpActive 8 years 28 daysSupal Lakhatariya and Panilamkumar Lakhatariya are mutual person
- Supal Pharmacare LimitedActive 1 year 5 months
Supal Lakhatariya, Panilamkumar Lakhatariya and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 19 May 2023 | ₹2.74 M | Open |
Bank Of India Creation Date: 19 May 2023 | ₹6.50 M | Open |
Bank Of India Creation Date: 19 May 2023 | ₹5.50 Cr | Open |
How Many Employees Work at Mono Pharmacare?
Mono Pharmacare has a workforce of 63 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mono Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mono Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
